Guardian Pharmacy Services, Inc.
GRDN
$38.87
$1.784.80%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 171.83% | 162.48% | 156.39% | 146.14% | -487.61% |
| Total Depreciation and Amortization | 11.77% | 13.58% | 12.96% | 12.49% | 10.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -87.13% | -86.28% | -85.59% | -82.39% | 870.65% |
| Change in Net Operating Assets | 62.19% | 60.19% | 121.70% | 126.79% | -432.11% |
| Cash from Operations | 71.45% | 32.77% | 72.97% | 75.36% | -14.14% |
| Capital Expenditure | 3.38% | -1.50% | -19.41% | -35.47% | -43.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 66.42% | 8.80% | 8.80% | -21.76% | -19.23% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.24% | -43.13% | 9.69% | -60.60% | -64.23% |
| Cash from Investing | 29.52% | 2.86% | -5.98% | -36.94% | -42.96% |
| Total Debt Issued | -- | -- | -- | -100.00% | -70.85% |
| Total Debt Repaid | 96.19% | 97.37% | 97.93% | 81.44% | 50.41% |
| Issuance of Common Stock | -79.66% | -50.48% | -75.76% | -75.76% | -- |
| Repurchase of Common Stock | -4.26% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | 69.44% |
| Other Financing Activities | 99.59% | 97.87% | 97.06% | 92.31% | -336.79% |
| Cash from Financing | 36.82% | 68.84% | 70.10% | -580.82% | 81.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 310.85% | 268.13% | 1,459.85% | -102.01% | 1,888.38% |